Advisory board

Leah Klapper  PhD, Chief Technology Officer, FutuRx Biotech Accelerator

Dr. Leah Klapper has been in R&D leadership positions in biotech start-ups for close to 20 years, advancing innovation from discovery to clinical proof of concept. Before joining FutuRx, she served as CSO at Regenovation and BioLineRx Ltd., and as VP R&D at CureTech Ltd. Dr. Klapper holds a PhD from the Weizmann Institute of Science. She did her post-doctoral training at the Fred Hutchinson Cancer Research Center in Seattle, Washington.

Zvika Slovin, Healthcare, investor and executive

Zvika Slovin has been Head of Elron's medical device investments since 2008. He is a serial entrepreneur, physicist, and well-rounded professional with broad experience in founding, managing, and successfully exiting Israeli start-up companies. Mr. Slovin holds a BSc and an MSc in Physics/Atmospheric Sciences from the Hebrew University and IMT International Campus.